Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 111

1.

Sabotage at the Powerhouse? Unraveling the Molecular Target of 2-Isopropylbenzaldehyde Thiosemicarbazone, a Specific Inhibitor of Aflatoxin Biosynthesis and Sclerotia Development in Aspergillus flavus, Using Yeast as a Model System.

Dallabona C, Pioli M, Spadola G, Orsoni N, Bisceglie F, Lodi T, Pelosi G, Restivo FM, Degola F.

Molecules. 2019 Aug 16;24(16). pii: E2971. doi: 10.3390/molecules24162971.

2.

Yeast expression of mammalian Onzin and fungal FCR1 suggests ancestral functions of PLAC8 proteins in mitochondrial metabolism and DNA repair.

Daghino S, Di Vietro L, Petiti L, Martino E, Dallabona C, Lodi T, Perotto S.

Sci Rep. 2019 Apr 29;9(1):6629. doi: 10.1038/s41598-019-43136-3.

3.

Deciphering OPA1 mutations pathogenicity by combined analysis of human, mouse and yeast cell models.

Del Dotto V, Fogazza M, Musiani F, Maresca A, Aleo SJ, Caporali L, La Morgia C, Nolli C, Lodi T, Goffrini P, Chan D, Carelli V, Rugolo M, Baruffini E, Zanna C.

Biochim Biophys Acta Mol Basis Dis. 2018 Oct;1864(10):3496-3514. doi: 10.1016/j.bbadis.2018.08.004. Epub 2018 Aug 4.

PMID:
30293569
4.

Defective mitochondrial rRNA methyltransferase MRM2 causes MELAS-like clinical syndrome.

Garone C, D'Souza AR, Dallabona C, Lodi T, Rebelo-Guiomar P, Rorbach J, Donati MA, Procopio E, Montomoli M, Guerrini R, Zeviani M, Calvo SE, Mootha VK, DiMauro S, Ferrero I, Minczuk M.

Hum Mol Genet. 2017 Nov 1;26(21):4257-4266. doi: 10.1093/hmg/ddx314.

5.

Dominance of yeast aac2R96H and aac2R252G mutations, equivalent to pathological mutations in ant1, is due to gain of function.

Dallabona C, Baruffini E, Goffrini P, Lodi T.

Biochem Biophys Res Commun. 2017 Nov 18;493(2):909-913. doi: 10.1016/j.bbrc.2017.09.122. Epub 2017 Sep 22.

PMID:
28947214
6.

Structural modification of cuminaldehyde thiosemicarbazone increases inhibition specificity toward aflatoxin biosynthesis and sclerotia development in Aspergillus flavus.

Degola F, Bisceglie F, Pioli M, Palmano S, Elviri L, Pelosi G, Lodi T, Restivo FM.

Appl Microbiol Biotechnol. 2017 Sep;101(17):6683-6696. doi: 10.1007/s00253-017-8426-y. Epub 2017 Jul 19.

PMID:
28725928
7.

Revision of Biliopancreatic Diversion for Side Effects or Insufficient Weight Loss: Codification of a New Procedure.

Ceriani V, Pinna F, Lodi T, Pontiroli AE.

Obes Surg. 2017 Apr;27(4):1091-1097. doi: 10.1007/s11695-017-2575-z.

PMID:
28197865
8.

Recurrent De Novo Dominant Mutations in SLC25A4 Cause Severe Early-Onset Mitochondrial Disease and Loss of Mitochondrial DNA Copy Number.

Thompson K, Majd H, Dallabona C, Reinson K, King MS, Alston CL, He L, Lodi T, Jones SA, Fattal-Valevski A, Fraenkel ND, Saada A, Haham A, Isohanni P, Vara R, Barbosa IA, Simpson MA, Deshpande C, Puusepp S, Bonnen PE, Rodenburg RJ, Suomalainen A, Õunap K, Elpeleg O, Ferrero I, McFarland R, Kunji ERS, Taylor RW.

Am J Hum Genet. 2016 Dec 1;99(6):1405. doi: 10.1016/j.ajhg.2016.11.001. No abstract available.

10.

Recurrent De Novo Dominant Mutations in SLC25A4 Cause Severe Early-Onset Mitochondrial Disease and Loss of Mitochondrial DNA Copy Number.

Thompson K, Majd H, Dallabona C, Reinson K, King MS, Alston CL, He L, Lodi T, Jones SA, Fattal-Valevski A, Fraenkel ND, Saada A, Haham A, Isohanni P, Vara R, Barbosa IA, Simpson MA, Deshpande C, Puusepp S, Bonnen PE, Rodenburg RJ, Suomalainen A, Õunap K, Elpeleg O, Ferrero I, McFarland R, Kunji ER, Taylor RW.

Am J Hum Genet. 2016 Oct 6;99(4):860-876. doi: 10.1016/j.ajhg.2016.08.014. Epub 2016 Sep 29. Erratum in: Am J Hum Genet. 2016 Dec 1;99(6):1405.

11.

Combined use of Saccharomyces cerevisiae, Caenorhabditis elegans and patient fibroblasts leads to the identification of clofilium tosylate as a potential therapeutic chemical against POLG-related diseases.

Pitayu L, Baruffini E, Rodier C, Rötig A, Lodi T, Delahodde A.

Hum Mol Genet. 2016 Feb 15;25(4):715-27. doi: 10.1093/hmg/ddv509. Epub 2015 Dec 21.

PMID:
26692522
12.

Validation of a MGM1/OPA1 chimeric gene for functional analysis in yeast of mutations associated with dominant optic atrophy.

Nolli C, Goffrini P, Lazzaretti M, Zanna C, Vitale R, Lodi T, Baruffini E.

Mitochondrion. 2015 Nov;25:38-48. doi: 10.1016/j.mito.2015.10.002. Epub 2015 Oct 8.

PMID:
26455272
13.

Biallelic Mutations of Methionyl-tRNA Synthetase Cause a Specific Type of Pulmonary Alveolar Proteinosis Prevalent on Réunion Island.

Hadchouel A, Wieland T, Griese M, Baruffini E, Lorenz-Depiereux B, Enaud L, Graf E, Dubus JC, Halioui-Louhaichi S, Coulomb A, Delacourt C, Eckstein G, Zarbock R, Schwarzmayr T, Cartault F, Meitinger T, Lodi T, de Blic J, Strom TM.

Am J Hum Genet. 2015 May 7;96(5):826-31. doi: 10.1016/j.ajhg.2015.03.010. Epub 2015 Apr 23.

14.

DNA polymerase γ and disease: what we have learned from yeast.

Lodi T, Dallabona C, Nolli C, Goffrini P, Donnini C, Baruffini E.

Front Genet. 2015 Mar 17;6:106. doi: 10.3389/fgene.2015.00106. eCollection 2015. Review.

15.

In vitro evaluation of the activity of thiosemicarbazone derivatives against mycotoxigenic fungi affecting cereals.

Degola F, Morcia C, Bisceglie F, Mussi F, Tumino G, Ghizzoni R, Pelosi G, Terzi V, Buschini A, Restivo FM, Lodi T.

Int J Food Microbiol. 2015 May 4;200:104-11. doi: 10.1016/j.ijfoodmicro.2015.02.009. Epub 2015 Feb 12.

PMID:
25702884
16.

Polymorphisms in DNA polymerase γ affect the mtDNA stability and the NRTI-induced mitochondrial toxicity in Saccharomyces cerevisiae.

Baruffini E, Ferrari J, Dallabona C, Donnini C, Lodi T.

Mitochondrion. 2015 Jan;20:52-63. doi: 10.1016/j.mito.2014.11.003. Epub 2014 Nov 18.

17.

Mitochondrial thiol oxidase Erv1: both shuttle cysteine residues are required for its function with distinct roles.

Ang SK, Zhang M, Lodi T, Lu H.

Biochem J. 2014 Jun 1;460(2):199-210. doi: 10.1042/BJ20131540.

18.

FLO11 expression and lipid biosynthesis are required for air-liquid biofilm formation in a Saccharomyces cerevisiae flor strain.

Zara G, Goffrini P, Lodi T, Zara S, Mannazzu I, Budroni M.

FEMS Yeast Res. 2012 Nov;12(7):864-6. doi: 10.1111/j.1567-1364.2012.00831.x. Epub 2012 Aug 6.

19.

Overexpression of DNA polymerase zeta reduces the mitochondrial mutability caused by pathological mutations in DNA polymerase gamma in yeast.

Baruffini E, Serafini F, Ferrero I, Lodi T.

PLoS One. 2012;7(3):e34322. doi: 10.1371/journal.pone.0034322. Epub 2012 Mar 28.

20.

Insights into physiological and genetic mupirocin susceptibility in bifidobacteria.

Serafini F, Bottacini F, Viappiani A, Baruffini E, Turroni F, Foroni E, Lodi T, van Sinderen D, Ventura M.

Appl Environ Microbiol. 2011 May;77(9):3141-6. doi: 10.1128/AEM.02540-10. Epub 2011 Mar 18.

21.

Roux-en-Y reconstruction at greater curvature in biliopancreatic diversion: effects on early postoperative functional recovery.

Ceriani V, Lodi T, Porta A, Roncaglia O, Osio C, Faleschini E, Bignami P, Coladonato M, Elnabil-Mortada A, Belloni A, Baldoli D, Gaffuri P.

Obes Surg. 2011 Aug;21(8):1188-93. doi: 10.1007/s11695-011-0378-1.

PMID:
21399972
22.

Predicting the contribution of novel POLG mutations to human disease through analysis in yeast model.

Baruffini E, Horvath R, Dallabona C, Czermin B, Lamantea E, Bindoff L, Invernizzi F, Ferrero I, Zeviani M, Lodi T.

Mitochondrion. 2011 Jan;11(1):182-90. doi: 10.1016/j.mito.2010.09.007. Epub 2010 Sep 29.

PMID:
20883824
23.

Laparoscopic versus open biliopancreatic diversion: a prospective comparative study.

Ceriani V, Lodi T, Porta A, Gaffuri P, Faleschini E, Roncaglia O, Osio C, Coladonato M, Elnabil-Mortada A.

Obes Surg. 2010 Oct;20(10):1348-53. doi: 10.1007/s11695-010-0140-0.

PMID:
20383755
24.

Construction and validation of a yeast model system for studying in vivo the susceptibility to nucleoside analogues of DNA polymerase gamma allelic variants.

Baruffini E, Lodi T.

Mitochondrion. 2010 Mar;10(2):183-7. doi: 10.1016/j.mito.2009.10.002. Epub 2009 Nov 1.

PMID:
19887119
25.

A variable neurodegenerative phenotype with polymerase gamma mutation.

Stricker S, Prüss H, Horvath R, Baruffini E, Lodi T, Siebert E, Endres M, Zschenderlein R, Meisel A.

J Neurol Neurosurg Psychiatry. 2009 Oct;80(10):1181-2. doi: 10.1136/jnnp.2008.166066. No abstract available.

PMID:
19762913
26.

Construction and characterization of centromeric, episomal and GFP-containing vectors for Saccharomyces cerevisiae prototrophic strains.

Baruffini E, Serafini F, Lodi T.

J Biotechnol. 2009 Sep 25;143(4):247-54. doi: 10.1016/j.jbiotec.2009.08.007. Epub 2009 Aug 14.

PMID:
19683551
27.

The mitochondrial disulfide relay system protein GFER is mutated in autosomal-recessive myopathy with cataract and combined respiratory-chain deficiency.

Di Fonzo A, Ronchi D, Lodi T, Fassone E, Tigano M, Lamperti C, Corti S, Bordoni A, Fortunato F, Nizzardo M, Napoli L, Donadoni C, Salani S, Saladino F, Moggio M, Bresolin N, Ferrero I, Comi GP.

Am J Hum Genet. 2009 May;84(5):594-604. doi: 10.1016/j.ajhg.2009.04.004. Epub 2009 Apr 30.

28.

No adjustment vs. adjustment formula as input weight for propofol target-controlled infusion in morbidly obese patients.

La Colla L, Albertin A, La Colla G, Ceriani V, Lodi T, Porta A, Aldegheri G, Mangano A, Khairallah I, Fermo I.

Eur J Anaesthesiol. 2009 May;26(5):362-9. doi: 10.1097/EJA.0b013e328326f7d0.

PMID:
19307972
29.

Oxygen is required to restore flor strain viability and lipid biosynthesis under fermentative conditions.

Zara G, Angelozzi D, Belviso S, Bardi L, Goffrini P, Lodi T, Budroni M, Mannazzu I.

FEMS Yeast Res. 2009 Mar;9(2):217-25. doi: 10.1111/j.1567-1364.2008.00472.x.

30.

Characterization of KlGUT2, a gene of the glycerol-3-phosphate shuttle, in Kluyveromyces lactis.

Saliola M, Sponziello M, D'Amici S, Lodi T, Falcone C.

FEMS Yeast Res. 2008 Aug;8(5):697-705. doi: 10.1111/j.1567-1364.2008.00386.x. Epub 2008 May 22.

31.

Behaviour of Saccharomyces cerevisiae wine strains during adaptation to unfavourable conditions of fermentation on synthetic medium: cell lipid composition, membrane integrity, viability and fermentative activity.

Mannazzu I, Angelozzi D, Belviso S, Budroni M, Farris GA, Goffrini P, Lodi T, Marzona M, Bardi L.

Int J Food Microbiol. 2008 Jan 15;121(1):84-91. Epub 2007 Nov 12.

PMID:
18055051
33.

Evolution of the carboxylate Jen transporters in fungi.

Lodi T, Diffels J, Goffeau A, Baret PV.

FEMS Yeast Res. 2007 Aug;7(5):646-56. Epub 2007 May 10.

34.

Induction and characterization of morphologic mutants in a natural Saccharomyces cerevisiae strain.

Barberio C, Bianchi L, Pinzauti F, Lodi T, Ferrero I, Polsinelli M, Casalone E.

Can J Microbiol. 2007 Feb;53(2):223-30.

PMID:
17496970
35.

KNQ1, a Kluyveromyces lactis gene encoding a transmembrane protein, may be involved in iron homeostasis.

Marchi E, Lodi T, Donnini C.

FEMS Yeast Res. 2007 Aug;7(5):715-21. Epub 2007 Apr 12.

36.

Galactose transport in Kluyveromyces lactis: major role of the glucose permease Hgt1.

Baruffini E, Goffrini P, Donnini C, Lodi T.

FEMS Yeast Res. 2006 Dec;6(8):1235-42.

37.
38.

Deletion of the glucose-6-phosphate dehydrogenase gene KlZWF1 affects both fermentative and respiratory metabolism in Kluyveromyces lactis.

Saliola M, Scappucci G, De Maria I, Lodi T, Mancini P, Falcone C.

Eukaryot Cell. 2007 Jan;6(1):19-27. Epub 2006 Nov 3.

39.

Genetic and chemical rescue of the Saccharomyces cerevisiae phenotype induced by mitochondrial DNA polymerase mutations associated with progressive external ophthalmoplegia in humans.

Baruffini E, Lodi T, Dallabona C, Puglisi A, Zeviani M, Ferrero I.

Hum Mol Genet. 2006 Oct 1;15(19):2846-55. Epub 2006 Aug 29.

PMID:
16940310
40.

Femoral hernia repair. Kugel retroparietal approach versus plug alloplasty: a prospective study.

Ceriani V, Faleschini E, Sarli D, Lodi T, Roncaglia O, Bignami P, Osio C, Somalvico F.

Hernia. 2006 Apr;10(2):169-74. Epub 2006 Feb 16.

PMID:
16482402
41.

Mutation D104G in ANT1 gene: complementation study in Saccharomyces cerevisiae as a model system.

Lodi T, Bove C, Fontanesi F, Viola AM, Ferrero I.

Biochem Biophys Res Commun. 2006 Mar 17;341(3):810-5. Epub 2006 Jan 19.

PMID:
16438935
42.

[Intraperitoneal hyperthermic chemotherapy. Preliminary experience with 22 consecutive patients].

Ceriani V, Bignami P, Faleschini E, Lodi T, Roncaglia O, Osio C, Sarli D.

Suppl Tumori. 2005 May-Jun;4(3):S124-5. Italian.

PMID:
16437945
43.

[D2 gastrectomy in the surgical treatment of gastric cancer].

Ceriani V, Bignami P, Faleschini E, Lodi T, Roncaglia O, Osio C, Sarli D.

Suppl Tumori. 2005 May-Jun;4(3):S92. Italian.

PMID:
16437925
44.

Kugel hernia repair: open "mini-invasive" technique. Personal experience on 620 patients.

Ceriani V, Faleschini E, Bignami P, Lodi T, Roncaglia O, Osio C, Sarli D.

Hernia. 2005 Dec;9(4):344-7. Epub 2005 Nov 19.

PMID:
16328156
45.

Complete loss-of-function of the heart/muscle-specific adenine nucleotide translocator is associated with mitochondrial myopathy and cardiomyopathy.

Palmieri L, Alberio S, Pisano I, Lodi T, Meznaric-Petrusa M, Zidar J, Santoro A, Scarcia P, Fontanesi F, Lamantea E, Ferrero I, Zeviani M.

Hum Mol Genet. 2005 Oct 15;14(20):3079-88. Epub 2005 Sep 9.

PMID:
16155110
46.

Secretion of human serum albumin by Kluyveromyces lactis overexpressing KlPDI1 and KlERO1.

Lodi T, Neglia B, Donnini C.

Appl Environ Microbiol. 2005 Aug;71(8):4359-63.

47.
48.

Helicobacter pylori clearance and eradication with triple therapy in duodenal ulcer patients. 1995.

Qureshi H, Ahmed W, Syed S, Lodi TZ, Zuberi SJ.

J Pak Med Assoc. 2004 Aug;54(8 Suppl):S63-4. No abstract available.

PMID:
15485199
49.

Immunogenicity of yeast-derived hepatitis B vaccine in Pakistani adults. 1990.

Zuberi SJ, Lodi TZ, Hassan R, Alam SE.

J Pak Med Assoc. 2004 Aug;54(8 Suppl):S61-2. No abstract available.

PMID:
15485198
50.

Hepatitis and hepatitis B surface antigen in health-care personnel. 1977.

Zuberi SJ, Samad F, Lodi TZ, Ibrahim K, Maqsood R.

J Pak Med Assoc. 2004 Aug;54(8 Suppl):S53-5. No abstract available.

PMID:
15485195

Supplemental Content

Support Center